Hasvet Pharma is the umbrella brand that brings together all veterinary pharmaceutical operations under a single structure. Operating through an integrated production, distribution, and marketing model, Hasvet Pharma conducts veterinary pharmaceutical manufacturing and distribution across three specialized facilities focused on different product groups, with a high annual production capacity of up to 59 million packs.
All manufacturing processes are carried out in compliance with GMP (Good Manufacturing Practices) standards, supported by an integrated quality management system covering quality control, traceability, and product safety. Hasvet Pharma adopts a production approach fully aligned with licensing and regulatory requirements, prioritizing a sustainable and reliable supply of veterinary pharmaceuticals. Its broad product portfolio includes preventive and therapeutic veterinary pharmaceutical solutions for different animal species and areas of use.
Pi Farma Production Facility
Pİ FARMA, established on a 7,200 m² site with a 3,800 m² enclosed production area, is one of Türkiye’s leading manufacturing facilities, with its GMP-certified infrastructure
and modern technology. The facility has an annual production capacity of approximately 7 million boxes.
Production Lines:
1 Non-Beta Lactam Sterile Injectable Production Line
1 Complementary Feed Production Line
1 Ectoparasiticide Production Line
FDN İlaç Production Facility
FDN İlaç, established on a 4,923 m² site with a 6,082 m² enclosed production area, is among the leading facilities in the sector, with its GMP-certified advanced production
lines and modern technology. The facility has an annual production capacity of approximately 22 million boxes.
Production Lines:
2 Non-Beta Lactam Sterile Injectable Production Lines
1 Beta Lactam / Hormone Sterile Injectable Production Line
Vilsan Manufacturing Facility
VİLSAN, established on a 13,500 m² site with a 10,700 m² enclosed production area, is one of Türkiye’s major manufacturing plants, equipped with GMP-certified modern
production lines and advanced technology. The facility has an annual production capacity of approximately 30 million boxes and exports to more than 20 countries.
Production Lines:
2 Non-Beta Lactam Sterile Injectable Production Lines
1 Beta Lactam Sterile Injectable Production Line
1 Oral Liquid Production Line
1 Tablet Production Line
1 Non-Beta Lactam Powder Production Line
1 Beta Lactam Intramammary Production Line
1 Beta Lactam Powder Production Line
1 Ectoparasiticide Production Line